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We have recently reported that fluorocarbon gases exhibit an effective fluidizing effect on Langmuir monolayers of dipalmitoyl
phosphatidylcholine (DPPC), preventing them from crystallizing up to surface pressures of ∼40 mN m−1, i.e. well above the DPPC's
equilibrium surface pressure. We now report that gaseous perfluorooctyl bromide (gPFOB) promotes the re-spreading of DPPC Langmuir
monolayers compressed on a bovine serum albumin (BSA)-containing sub-phase. The latter protein is known to maintain a concentration-
dependent surface pressure that can exceed the re-spreading pressure of collapsed monolayers. This phenomenon was proposed to be responsible
for lung surfactant inactivation. Compression/expansion isotherms and fluorescence microscopy experiments were carried out to assess the
monolayers' physical state. We have found that, during expansion under gPFOB-containing air, the surface pressure of a DPPC monolayer on a
BSA-containing sub-phase decreased to much lower values than when the DPPC monolayer was expanded in the presence of BSA under air
(∼0 mN m−1 vs. ∼7.5 mN m−1 at 120 Å2, respectively). Moreover, fluorescence images showed that, during expansion, the BSA-coupled
DPPC monolayers, in contact with gPFOB, remained in the liquid-expanded state for surface pressures lower than 10 mN m−1, whereas they
were in a liquid-condensed semi-crystalline state, even at large molecular areas (120 Å2), when expanded under air. The re-incorporation of the
PFOB molecules in the DPPC monolayer during expansion thus competes with the re-incorporation of BSA, thus preventing the latter from
penetrating into the DPPC monolayer. We suggest that combinations of DPPC and a fluorocarbon gas may be useful in the treatment of lung
conditions resulting from a deterioration of the native lung surfactant function due to plasma proteins, such as in the acute respiratory distress
syndrome.
© 2006 Elsevier B.V. All rights reserved.Keywords: Dipalmitoyl phosphatidylcholine; Fluorocarbon; Perfluorooctyl bromide; Serum albumin; Langmuir monolayer; Fluorescence microscopy; Lung
surfactant; Acute respiratory distress syndrome1. Introduction
Protein adsorption at bio-interfaces plays a pivotal role in
many biotechnological and medical applications. One parti-
cular example of bio-interface is the lung surfactant (LS). The
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doi:10.1016/j.bbamem.2006.09.022dipalmitoyl phosphatidylcholine (DPPC), neutral lipids, and
four proteins designated SP-A, SP-B, SP-C and SP-D [1]. The
main function of LS is to lower the work of breathing by
reducing the surface tension at the air/water interface of the
terminal airways to values as low as ∼1 mN m−1 during
expiration [2]. DPPC is generally accepted as being the lipid
responsible for generating the near-zero surface tension
needed at the interface [3]. It is also essential that LS be
able to re-spread rapidly at the alveolar surface during
inspiration.
Lack of effective surfactant in premature babies most
often results in neonatal respiratory distress syndrome
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(RLS) from animal origin has been reported beneficial and
significantly reduces mortality rates [4]. Examples of such
RLS include commercial preparations extracted from bovine
(Survanta®, Ross Laboratories, Columbus, Ohio, USA) or
porcine (Curosurf®, Chiesi Pharmaceutici, Parma, Italy) lungs
[5].
Another severe lung condition, the acute respiratory
distress syndrome (ARDS), shares many of the NRDS
symptoms. However, ARDS does not respond positively to
RLS therapy because ARDS is a more complicated pathology
than the simple absence of surfactant [4]. In ARDS,
substantial leakage of plasma proteins and inflammatory
mediators, such as albumin, C-reactive protein, hemoglobin
and fibrinogen, occurs in the alveolar spaces [6,7]. The lack
of efficacy of RLS therapy in ARDS results from the fact that
plasma proteins and mediators exasperate LS function
deterioration [8,9]. Numerous in vitro studies have demon-
strated the surfactant inhibition properties of plasma proteins,
in particular albumin [10,11].
More precisely, it has been demonstrated that serum
albumin exercises a concentration-dependent surface pressure
that can exceed the re-spreading pressure of collapsed
monolayers in vitro [4]. As a result, the collapsed surfactant
monolayer cannot re-spread effectively during expansion,
leading to higher minimum surface pressure and to
alteration of the compression/expansion isotherms. It was
concluded that the re-spreading pressure may be as
important as the minimum surface tension in the design of
new replacement surfactants that could be beneficial in
ARDS therapy [4].
We have recently reported that a fluorocarbon gas (gFC)
provides a highly effective fluidizing effect on a DPPC
monolayer, preventing it from crystallizing during compres-
sion, and hence, from loosing its LS properties [12,13]. It was
also found that gFC facilitated the re-spreading of DPPC
molecules during expansion. The specific properties of
fluorocarbons, including exceptional chemical and biological
inertness, high gas-dissolving capacity, low surface tension,
excellent spreading characteristic and high fluidity, have
triggered numerous applications of these compounds in
diagnosis and therapy [14–17]. We have suggested that
certain fluorocarbons, in combination with DPPC, may prove
useful in RLS compositions [18].
The primary goal of the present study was to evaluate the
effect of gaseous perfluorooctyl bromide (gPFOB) on a
DPPC monolayer compressed over a sub-phase containing
bovine serum albumin (BSA). PFOB has been chosen
because it has been selected for intravascular oxygen
transport [15,19] and liquid ventilation [20]. The isotherms
of DPPC monolayers compressed and expanded on pure
water, or on a sub-phase containing BSA, have been
determined. In each experiment, the atmosphere above the
monolayer was air, or air saturated with gPFOB. The physical
state of the monolayers, fluid liquid-expanded (LE) or semi-
crystalline liquid-condensed (LC), was investigated using
fluorescence microscopy (FM).2. Materials and methods
2.1. Materials
Perfluorooctyl bromide (PFOB, perflubron) was kindly provided by Alliance
Pharmaceutical Corp. (San Diego, CA, USA). L-α-l,2-dipalmitoyl-sn-3-glycero-
phosphatidylcholine (DPPC, purity >99%) and bovine serum albumin (BSA,
essentially fatty acid free, purity >96%) came from Sigma. Spreading solutions
of DPPC (1.0 mmol L−1) were prepared in analytical grade chloroform. Water
was purified using aMillipore system (pH=5.5; surface tension: 72.1 mNm−1 at
20 °C; resistivity: 18MΩ cm). The fluorescent dye (2-[6-(7-nitrobenz-2-oxa-l,3-
diazol-4-yl)amino]hexanoyl-l-hexadecanoyl-sn-glycero-3-phosphocholine,
NBDC6-HPC)was purchased fromMolecular Probes (Eugene, OR, USA). It was
used at a lipid mole ratio of 1%. Saturation of air with PFOB at 25 °C leads to a
PFOB concentration of 0.5 mL L−1.
2.2. Compression isotherms
Surface pressure (π) versus molecular area (A) isotherms were recorded on a
Langmuir minitrough (Riegler and Kirstein, Potsdam, Germany) with a working
surface area of∼120 cm2 and a sub-phase volume of∼100 mL. The trough was
equipped with two movable barriers (compression speed: 4 Å2 molecule−1
min−1). π was measured using the Wilhelmy plate method. The trough was
enclosed in a gas-tight box that was flushed with air or with air saturated with
gPFOB, depending on the experiments. In the latter case, air was allowed to
bubble at room temperature through liquid PFOB before being flushed into the
gas-tight box. The flow rate of the gas phase (air or gPFOB-saturated air) was set
to 1.2 L min−1. Under these conditions, the evaporation rate of PFOB was
measured to be∼6 mL h−1. Temperature was regulated at 25±0.5 °C. The errors
on π and A were estimated to ±1 mN m−1 and 1 Å2, respectively. In the
experiments where DPPC monolayers were compressed on water, 15 μL of the
DPPC spreading solution were spread on water and the spreading solvent was
allowed to evaporate for 15 min before compression. In experiments involving
BSA, 15 μL of the DPPC spreading solution were spread on a cleaned sub-phase
containing BSA (0.25 mg L−1) in order to avoid pre-adsorption of the protein.
The isotherms were recorded 1 h30 after spreading of the DPPC solution. The
pH of the sub-phase was ∼6.8. The isoelectric point of BSA is 5.4.
2.3. Fluorescence microscopy
Fluorescence microscopy (FM) was achieved with the above balance
equipped with an Olympus fluorescence microscope (20× power objective)
mounted on a xy translation stage, so as to allow scanning of the trough over
different regions. An Olympus 100 W high-pressure mercury lamp was used for
excitation. A dichroic mirror/barrier filter assembly was used to filter and direct
the excitation light onto the monolayer (450–490 nm) and to filter out the
emitted fluorescence (520 nm). The emitted fluorescence was collected by the
objective and detected via a Hamamatsu intensified camera. The microscope
was linked to the gas-tight box of the trough through an extensible gusset,
allowing control of the partial pressure of PFOB. The surface pressure was kept
constant during the FM experiments. The fluorescent probe NBDC6-HPC is
soluble into liquid-expanded (disordered) phases, which appear bright under the
microscope, and is excluded from the liquid-condensed (semi-crystalline)
phases, which then appear as dark domains in the images [21].
3. Results and discussion
3.1. Isotherms of Langmuir monolayers of DPPC
3.1.1. On pure water
When compressed under air, DPPC underwent a first order
phase transition from a liquid-expanded (LE) state to a liquid-
condensed (LC) state at a surface pressure of π ∼13 mN m−1,
as shown by the presence of a plateau on the isotherm (Fig. 1)
[22]. At the onset of the LE/LC coexistence region, as
Fig. 2. π/A isotherms of a DPPC Langmuir monolayer spread on a sub-
phase containing BSA compressed under air. The first compression—
expansion cycle is represented by a solid line and the second compression
by a dashed line. FM images of the DPPC monolayer upon compression at
(a) 30 mN m−1, (b) 40 mN m−1 and (c) 71 mN m−1, and, upon expansion,
at (d) 80 Å2 (25 °C).
Fig. 1. Surface pressure (π) versus molecular area (A) isotherms of a Langmuir
monolayer of DPPC compressed on pure water (25±0.5 °C) under air. The first
compression—expansion cycle is represented by a solid line and the second
compression by a dashed line. Fluorescence micrographs of the DPPC
monolayer at (a) 2 mN m−1, (b) 13 mN m−1 and (c) 20 mN m−1, show the
formation of semi-crystalline LC domains in the last two cases. The fluorescent
dye is preferentially soluble in the disordered liquid-expanded regions of the
monolayer, which appear bright, while the liquid-condensed domains, from
which the dye is excluded, appear dark [21].
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numerous upon compression, and progressively merged into a
continuous LC phase.
Monitoring the expansion of the DPPC monolayer by FM
showed the progressive fragmentation of the continuous LC
phase into discrete LC domains. The size of the LC
domains progressively decreased, until they disappeared at
π<∼5 mN m−1 (A ∼80 Å2). When the DPPC monolayer was
subsequently re-compressed after expansion, no significant
variation was seen in the isotherms, which means that no
significant amount of DPPC molecules was desorbed to the sub-
phase during the compression/expansion cycle. The limiting
molecular area (A∞) was ∼50 Å2. The surface pressure of
collapse (πcoll) was ∼71 mN m−1, i.e. the minimum surface
tension was close to 1 mN m−1.
3.1.2. On a sub-phase containing bovine serum albumin
The influence of human serum albumin (HSA) on Langmuir
monolayers of various zwitterionic and anionic phospholipids
has been investigated using Brewster angle microscopy (BAM)
and grazing-incidence X-ray diffraction (GIXD) [23,26]. It was
shown that a mixed HSA/phospholipid monolayer was formed
that results from adsorption and penetration of the albumin into
the phospholipid monolayer. Upon compression, at 30 mNm−1,
the protein was squeezed out from the monolayer into the sub-
phase. Depending on the pH of the sub-phase, i.e. on the
electrostatic interactions between the protein and the phospho-
lipids, a variety of inhomogenous phases with various
morphologies (e.g. honeycomb, block, or stripe phases) were
observed by BAM. The phase behavior and structural changes
of monolayers of zwitterionic and anionic phospholipids
coupled with HAS have been investigated by GIXD.
The isotherms of the DPPC monolayer spread on a BSA-
containing sub-phase compressed under air are shown in Fig. 2.
Upon compression, the isotherm is significantly shifted toward
larger molecular area (A) values, as compared to the isotherm
obtained on pure water. At the beginning of the compression (A∼120 Å2), π is ∼20 mN m−1 in the presence of BSA, while it
is close to zero on pure water. This means that BSA is
incorporated into the DPPC monolayer upon compression and
forms a mixed DPPC/BSA monolayer, in agreement with
previous reports [23–26].
The physical state of the mixed DPPC/BSA monolayer has
been investigated by FM. For π<30 mN m−1, FM images
showed a dark grey, uniform phase. This phase is very different
from the bright and featureless images typical of fluid liquid-
expanded phases, as seen in Fig. 1a. The dark appearance of the
FM images indicates that the fluorescent dye is not soluble in
the mixed DPPC/BSA monolayer. This phase did not show any
presence of LC domains, which supports the fact that BSA had
penetrated into the monolayer and had interacted with the DPPC
molecules, preventing the formation of LC domains. However,
no specific features, such as inhomogeneous phases, as
suggested in [24], have been observed, probably due to the
difference of resolution between FM and BAM techniques.
For π>30 mN m−1, the shape of the compression isotherm
became more similar to that of DPPC spread on pure water. The
presence of numerous small LC domains forming a practically
continuous LC phase was observed (Fig. 2a), which shows that
BSA had been squeezed out from the DPPC monolayer,
allowing the formation of LC domains. The number and size of
these domains increased with π, until they formed a continuous
LC phase at ∼40 mN m−1 (Fig. 2b). The value of πcoll
(∼71 mN m−1) of the DPPC monolayer in the presence of BSA
and of A∞ (∼50 Å2), are similar to those obtained on pure water.
The fluorescence micrograph (Fig. 2c) illustrates a fracture of
the monolayer that occurred during collapse. Moreover, the
value of A∞ determined on the second compression was similar
to that measured after the first compression, which suggests that
the stability of the DPPC monolayer is not affected by the
presence of the BSA in the sub-phase.
Upon expansion of the DPPC monolayer, BSA was re-
adsorbed at the interface, maintaining a surface pressure of 20 to
10 mN m−1 for A ranging from 50 to 120 Å2. Monitoring
monolayer expansion clearly showed the role of BSA in
Fig. 4. π/A isotherms of a DPPC Langmuir monolayer spread on a sub-phase
containing BSA and compressed under gPFOB-saturated air (25 °C). The first
compression—expansion cycle is represented by a solid line and the second
compression by a dashed line. Fluorescence micrographs of the DPPC
monolayer (a) upon compression at 35 mN m−1 and (b) upon expansion at
80 Å2.
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expansion (A ∼120 Å2), π was still ∼7.5 mN m−1, instead of
∼0 mN m−1 in the absence of BSA. In parallel, FM showed
that, even at large A values (∼80 Å2), the phase was clearly not
fluid. Large regions of LC phase, hardly fragmented, were
visible (Fig. 2d). In other regions, numerous small LC domains
were present. By contrast, the DPPC monolayer expanded on
pure water under the same conditions was totally fluid. This
shows that BSA re-adsorption during expansion of the DPPC
monolayer prevented the re-spreading of the DPPC molecules,
which, in the case of lung surfactant, would hinder lung
function [4].
3.2. Isotherms of Langmuir monolayers of DPPC in contact
with a fluorocarbon gas
3.2.1. On pure water
The behavior of a DPPC monolayer compressed on pure
water under an atmosphere of air saturated with gPFOB has
recently been investigated by FM and GIXD [12,13]. The
gPFOB molecules adsorb and penetrate into the DPPC
monolayer (as assessed by the surface pressure increase on
the isotherm), drastically changing its phase behavior (Fig. 3).
The LE/LC phase transition pressure of DPPC, which was
typically found at ∼13 mN m−1 in the absence of gPFOB, was
increased to ∼40 mN m−1. The transition observed at ∼28 mN
m−1 in the presence of gPFOB was no longer of the LE/LC
type, but likely corresponds to a re-orientation of the PFOB
molecules inserted in the DPPC monolayer. The DPPC
monolayer in contact with gPFOB is in a homogenous, fluid
LE phase up to ∼40 mN m−1, above which the PFOB
molecules are excluded from the monolayer and likely form a
thin liquid film on top of the DPPC monolayer.
Upon expansion, below 40 mN m−1, the isotherm was
shifted towards larger molecular areas, indicating that the PFOB
molecules were reincorporated into the DPPC monolayer, thus
increasing the re-spreading properties of the DPPC molecules,
as assessed by FM. The DPPC monolayer contacted with
gPFOB was stable until ∼71 mN m−1 and no significant loss of
DPPC molecules to the sub-phase occurred during the
compression/expansion cycle. These experiments demonstrateFig. 3. π/A isotherms of a DPPC monolayer spread onto pure water under an
atmosphere of gPFOB-saturated air (25 °C). The first compression—expansion
cycle is represented by a solid line and the second compression by a dashed line.
FM images at (a) 13 mN m−1 and (b) 35 mN m−1 show that the DPPC
monolayer in contact with gPFOB remains fluid up to 40 mN m−1.that the gPFOB molecules interact with DPPC molecules and
prevent the formation of the LC phase, and hence, induce a
fluidizing effect in the monolayer.
3.2.2. On a sub-phase containing bovine serum albumin
Fig. 4 shows the isotherms of a DPPC monolayer spread on a
BSA-containing sub-phase and compressed under a gPFOB-
saturated air atmosphere. During the first compression, the
isotherm was significantly less shifted towards larger A values
than the isotherm of DPPC compressed on a BSA-containing
sub-phase under air. This indicates that, in the presence of
gPFOB molecules, the incorporation of BSA in the DPPC
monolayer is less pronounced. It is also noteworthy that the
initial surface pressure recorded with BSA in the sub-phase
when the DPPC monolayer was contacted with gPFOB was
lower than the initial surface pressure recorded in the absence of
gPFOB (i.e. 12 mN m−1 vs. 20 mN m−1, respectively). This
also indicates that the presence of gPFOB counteracts the
adsorption of BSA in the DPPC monolayer. The fact that, for
π<30 mN m−1, the FM images showed the dark grey uniform
phase already seen in Section 3.1.2, indicates that the presence
of gPFOB limits but does not totally inhibit the adsorption of
BSA. For 30 mN m−1 <π<40 mN m−1, a bright and featureless
image, typical of a LE phase, was seen. Within this pressure
range, BSA had been squeezed out, while PFOB molecules
were still present in the DPPC monolayer, resulting in a definite
fluidizing effect. For π>40 mN m−1, very small LC domains
were present on the FM images, meaning that the PFOB
molecules were being squeezed out and went on top of the
DPPC monolayer.
The striking point is that, contrarily to what happened in the
absence of gPFOB (Fig. 2), π decreased strongly upon
expansion, reaching even ∼0 mN m−1 for the largest A values
(∼120 Å2), as compared to 7.5 mN m−1 when BSAwas present
and gPFOB absent. This means that the presence of the
fluorocarbon molecules hindered the re-adsorption of the
protein upon expansion.
This view is confirmed by the FM images obtained at A
∼80 Å2, which were uniformly bright, meaning that the
monolayer was in the LE state (Fig. 4), as compared to the FM
494 F. Gerber et al. / Biochimica et Biophysica Acta 1768 (2007) 490–494images obtained in the presence of BSA, but without gPFOB,
which clearly showed the presence of LC domains (Fig. 2d). The
values of πcoll and A∞ obtained after the first compression, i.e.
∼71 mN m−1 and ∼50 Å2, respectively, show that the DPPC
monolayer was not destabilized when BSA and gPFOB were
present simultaneously. The second compression isotherm did
not show any significant difference with the first compression
isotherm.
4. Conclusions and perspectives
The presence of a fluorocarbon gas in the atmosphere above
a Langmuir monolayer of DPPC profoundly modifies the effect
of serum albumin on the compression/expansion behavior and
morphology of this monolayer. Most importantly, the isotherms
and fluorescence micrographs provide evidence that the
fluorocarbon gas facilitates the re-spreading of a collapsed
DPPC Langmuir monolayer during expansion on a sub-phase
containing bovine serum albumin. The substantial residual
surface pressure (π=7.5 mN m−1) still observed at the end of
expansion (A=120 Å2) when BSA is present in the sub-phase,
returns to essentially 0 mN m−1 when the fluorocarbon gas is
introduced in the atmosphere above the monolayer. In parallel,
the numerous LC domains seen on expansion of the DPPC
monolayer, even at large A values, when BSA is present, are no
longer seen when the fluorocarbon is added. The observed
fluidizing effect induced by the fluorocarbon thus counteracts
the deleterious effect of albumin, which adsorbs at the interface
during expansion, and develops a surface pressure that
maintains the DPPC monolayer in a liquid condensed state,
thus hindering lung function. These results suggest that
combinations of a fluorocarbon gas and DPPC could be useful
in the design of new replacement lung surfactants effective
against the acute respiratory syndrome, in which the inactiva-
tion of the lung surfactant is largely driven by serum proteins.
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